Form 4: NovoCure Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Mukund Paravasthu, Chief Operating Officer of NovoCure Ltd, sold 2,160 ordinary shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On January 11, 2025, Mukund Paravasthu, the Chief Operating Officer of NovoCure Ltd, sold 2,160 ordinary shares of the company.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- The shares were sold at a weighted average price of $26.8084, with individual trades ranging from $26.44 to $27.185.
- Following the transaction, Paravasthu directly owns 31,437 ordinary shares of NovoCure Ltd.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (sell to cover taxes) and has no inherent positive or negative implications for the company's outlook.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Key Dates
| Date | Description |
|---|---|
| 2024/10/01 | Date of execution of the Limited Power of Attorney. |
| 2025/01/11 | Date of the transaction (sale of shares). |
| 2025/01/15 | Date of signature of the Form 4 report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.